TrueMass

Truemass was founded in the Netherlands in 2020 and has manufacturing facilities based in Manchester, UK. TrueMass is presenting the world’s first commercially designed charge detection mass spectrometer (CDMS) at this year’s ASMS conference in Philadelphia, PA. Offering the ability to enhance mass spectrometry, widely used in small molecule detection, the TrueMass technology enables detailed analysis of macromolecules such as viruses. TrueMass optimizes CDMS technology for commercial application and was launched in direct response to the pandemic, borne out of the currently unmet need to be able to identify individual species of large molecules such as viruses. TrueMass is the brainchild of John Hoyes PhD. He has more than 30 years’ experience in the mass spectrometry industry with a long background in instrumentation design of mass and ion mobility spectrometers, most recently as Technical Director at Waters Manchester. John was awarded the prestigious HUPO (the Human Proteome Organization) Science and Technology Award in 2016 and was formerly a Waters Scientific Fellow. TrueMass optimizes CDMS technology for commercial application and was launched in direct response to the pandemic, borne out of the currently unmet need to be able to identify individual species of large molecules such as viruses. TrueMass is developing its prototype to proof of concept, with the goal of bringing the technology to commercial application, driving forward research into macromolecules in academia and clinical labs worldwide.